Oppenheimer Inc. (OPY) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Oppenheimer Inc.

    NYSE: OPY · Real-Time Price · USD
    72.66
    -1.78 (-2.39%)
    At close: Sep 05, 2025, 3:59 PM
    73.19
    0.73%
    After-hours: Sep 05, 2025, 06:05 PM EDT

    Oppenheimer Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 1.43B 1.25B 1.11B 1.39B
    Cost of Revenue
    		 964.46M 807.32M 766.39M 909.15M
    Gross Profit
    		 468.04M 441.5M 344.55M 484.89M
    Operating Income
    		 304.83M 284.18M 199.18M 234.5M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 105.76M 46.77M 45.55M 224.64M
    Net Income
    		 71.56M 30.18M 32.35M 158.96M
    Selling & General & Admin
    		 163.21M 157.32M 145.37M 140.59M
    Research & Development
    		 n/a n/a n/a n/a
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 163.21M 157.32M 145.37M 140.59M
    Interest Expense
    		 87.99M 68.6M 23.85M 9.86M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 1.13B 964.65M 911.76M 1.05B
    Income Tax Expense
    		 34.51M 16.5M 13.44M 65.68M
    Shares Outstanding (Basic)
    		 10.35M 10.74M 11.67M 12.64M
    Shares Outstanding (Diluted)
    		 11.23M 11.65M 12.61M 13.58M
    EPS (Basic)
    		 6.93 2.81 2.77 12.57
    EPS (Diluted)
    		 6.37 2.59 2.57 11.70
    EBITDA
    		 231.03M 152.57M 103.81M 268.62M
    EBIT
    		 193.75M 115.37M 69.4M 234.5M
    Depreciation & Amortization
    		 37.28M 37.2M 34.41M 34.12M

    Add to Watchlist